Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Eli Lilly’s investment is seen as an opportunity to drive economic growth for the UK while improving public health.
Social Responsibility
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
Vifor Pharma offers £23m to NHS to resolve CMA investigation
FDA shares additional draft guidance on CGTs
Zentiva voices UWWTD concerns as EU grants approval
UPFs fuelling ‘alarming rise of chronic diseases’ in india
Global conflicts prompt GPEI to delay polio eradication target
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication
